| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MP.2014.54 |
| P698 | PubMed publication ID | 24912493 |
| P50 | author | Carol Tamminga | Q29904486 |
| P2093 | author name string | M Yanagi | |
| C Zhao | |||
| C Choi | |||
| S Ghose | |||
| J J Bartko | |||
| K Hulsey | |||
| A D Stan | |||
| P Mihalakos | |||
| S U Morris | |||
| P2860 | cites work | Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 |
| Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
| Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. | Q45950519 | ||
| Proton MRS in twin pairs discordant for schizophrenia | Q46470298 | ||
| Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study | Q46600035 | ||
| Brain gamma-aminobutyric acid measurement by proton double-quantum filtering with selective J rewinding | Q46609741 | ||
| Molecular evidence for mitochondrial dysfunction in bipolar disorder | Q48017201 | ||
| Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders | Q48689946 | ||
| Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. | Q48948657 | ||
| Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia | Q49025744 | ||
| NMDA-dependent modulation of CA1 local circuit inhibition. | Q49058538 | ||
| Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. | Q50803831 | ||
| Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. | Q51032268 | ||
| A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia | Q61713924 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| Analysis of macromolecule resonances in 1H NMR spectra of human brain | Q72866495 | ||
| Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia | Q73939019 | ||
| Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study | Q81245412 | ||
| Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression | Q95827751 | ||
| Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network | Q28510934 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Hippocampal interneurons are abnormal in schizophrenia | Q30503608 | ||
| A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. | Q30577998 | ||
| In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. | Q30761238 | ||
| Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 | ||
| Simultaneous in vivo spectral editing and water suppression | Q31982014 | ||
| De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. | Q33398247 | ||
| Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia | Q33404028 | ||
| Proton magnetic resonance spectroscopy in 22q11 deletion syndrome | Q33955280 | ||
| Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies | Q33957510 | ||
| Alterations of cortical GABA neurons and network oscillations in schizophrenia. | Q34058473 | ||
| Effects of ketamine in normal and schizophrenic volunteers | Q34091266 | ||
| Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy | Q34116142 | ||
| Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. | Q34160826 | ||
| Patterns of cerebral blood flow in schizophrenia | Q34351973 | ||
| Human postmortem tissue: what quality markers matter? | Q34574442 | ||
| Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders | Q34828363 | ||
| Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia | Q36323522 | ||
| Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging | Q36351638 | ||
| Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations | Q36618870 | ||
| 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas | Q36738040 | ||
| In vivo measurements of glutamate, GABA, and NAAG in schizophrenia | Q37131013 | ||
| Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia | Q37199826 | ||
| The Hippocampal Formation in Schizophrenia | Q37784600 | ||
| Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia | Q42200896 | ||
| Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. | Q43095693 | ||
| Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. | Q43757912 | ||
| New insights into the role of thyroid hormone in the CNS: the microglial track | Q43861789 | ||
| Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia | Q44014143 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 433-439 | |
| P577 | publication date | 2014-06-10 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia | |
| P478 | volume | 20 |
| Q36668986 | Alterations in hippocampal connectivity across the psychosis dimension |
| Q36241105 | Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging |
| Q31090438 | Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies |
| Q38932809 | Cell-based therapies for the treatment of schizophrenia |
| Q36575926 | Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study. |
| Q38798058 | Developmental expression of mGlu2 and mGlu3 in the mouse brain |
| Q47572745 | Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice |
| Q26752657 | GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies |
| Q48557473 | Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample |
| Q90748306 | Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study |
| Q90826039 | Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis |
| Q60460243 | Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder |
| Q34254463 | Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction |
| Q47336061 | Mice lacking a functional NMDA receptor exhibit social subordination in a group-housed environment. |
| Q59880655 | Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction |
| Q30383611 | Molecular substrates of schizophrenia: homeostatic signaling to connectivity |
| Q60046151 | Neurobiological Determinants of Tobacco Smoking in Schizophrenia |
| Q36393853 | Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis |
| Q50025633 | Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis |
| Q50152745 | Prenatal Immune Challenge in Mice Leads to Partly Sex-Dependent Behavioral, Microglial, and Molecular Abnormalities Associated with Schizophrenia |
| Q90427486 | Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors |
| Q30982690 | Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology |
| Q38691885 | Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. |
| Q37349910 | Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment |
| Q33920257 | The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment |
| Q61798989 | The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice |
| Q26860217 | Translating the MAM model of psychosis to humans |
| Q28771512 | Transmembrane protein 108 is required for glutamatergic transmission in dentate gyrus |
Search more.